Bunge Global SA ($BG)

HR8591, the No Capital Gains Tax on Family Farms Act, was introduced and referred to the House Committee on Ways and Means on April 30, 2026. At this early stage with no committee action, hearings, or markup, the bill has no near-term market impact. No specific companies or sectors are materially affected until legislative progress occurs.

HR 8646 is a procedural step in the annual agriculture appropriations process for FY2027. The reported bill text provides standard funding levels for USDA agencies and farm programs, but contains no major policy changes or spending shocks. Market impact is negligible — tickers ADM, BG, DE face no revenue or margin changes from this bill's current state.

→ Sustains USDA funding at current operational levels; the bill text enumerates specific appropriations (e.g., $55.261M for Office of the Secretary with detailed sub-allocations). No new major programs or funding shifts are evident from the text. Market prices for agricultural commodities and agribusiness margins remain at baseline because there is no change to subsidy levels, crop insurance, or trade programs.

HR8374 is a structural policy bill introduced in the House that would remove statutory references to 'socially disadvantaged farmers and ranchers' from federal agriculture programs. The bill is in early legislative stages (referred to committee) with no clear path to passage, and no funding authorization or appropriation is involved. Direct market impact is negligible.

The Checkoff Transparency Act (HR7851) is a procedural transparency bill requiring USDA to publish existing audit and budget documents for commodity checkoff programs. It alters no market mechanisms, no revenue streams, and no funding for any publicly traded company. No market impact is expected.

The Farm and Family Relief Act (HR7206) is an early-stage, unfunded bill that would provide one-time payments to commodity producers for the 2025 crop year and delay SNAP benefit reductions to 2032. No funding is authorized or appropriated; the bill has been referred to three committees with no further action since January 2026. Market data for $ADM and $BG shows these stocks near 52-week highs with strong recent momentum, but this is driven by factors other than this stalled legislation.

→ Same: zero funding committed; no economic transfer.

S. 525 is a purely procedural bill transferring administrative functions for the Food for Peace Act from USAID to USDA. It authorizes no new funding, changes no program scope, and directly affects no public company revenue streams. The bill has advanced no further than committee referral since introduction 14 months ago, indicating negligible near-term market relevance.

HR5710 suspends payment limits and authorizes advance partial payments for ARC/PLC programs for crop year 2025. The bill is in early legislative stages with no further action since referral to the House Agriculture Committee in October 2025. No market-moving impact is expected in the near term.

The Reclaim Trade Powers Act (HR2459) has been introduced in the House and referred to the Ways and Means Committee. It would repeal the President's authority to impose temporary tariffs of up to 15% to address balance-of-payments deficits. At this early procedural stage with zero markup or Senate action, there is no direct, measurable market impact.

The CROP Act (S.3297) proposes a temporary, retroactive reinstatement of the $1.00/gallon biodiesel tax credit through May 31, 2026. The bill sits in early legislative stage — introduced in the Senate with a single sponsor and referred to Finance Committee. No companion bill exists in the House. Passage probability is low in current form. If enacted, the credit directly improves margins for biodiesel producers and their feedstock suppliers.

→ Improved biodiesel production margins by ~$1.00/gallon for eligible fuel sold or used during the credit window.

The Specialty CROP Act of 2026 (S. 3915) is an early-stage procedural bill that mandates a new annual USDA report on foreign trade barriers for specialty crops. It authorizes zero funding, imposes no obligations on any private company, and has no material financial impact on any public company or sector.